Form4insider filings, from the source

SEC Form 4 · accession 0001103780-15-000022

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher Bunka
Officer — CEO · Director · 10% Owner
Period of report
Jan 20, 2010
Accepted (ET)
May 7, 2015 · 1:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common SharesMay 6, 2015P75,000$0.14A3,705,794D
Common SharesMay 6, 2015P50,000$0.137A3,755,794D
Common SharesMay 6, 2015P100,000$0.136A3,855,794D
Common SharesMay 6, 2015P10,000$0.1325A3,865,794D
Common SharesMay 6, 2015P13,000$0.1339A3,878,794D
Common SharesMay 6, 2015P5,000$0.134A3,883,794D
Common SharesMay 6, 2015P7,000$0.1294A3,890,794D
Common SharesMay 6, 2015P30,000$0.129A3,920,794D
Common SharesMay 6, 2015P12,000$0.129A3,932,794D
Common SharesMay 6, 2015P10,000$0.1258A3,942,794D
Common SharesMay 6, 2015P5,000$0.1289A3,947,794D
Common SharesMay 6, 2015P5,000$0.1221A3,952,794D
Common SharesMay 6, 2015P11,000$0.1244A3,963,794D
Common SharesMay 6, 2015P10,000$0.1243A3,973,794D
Common SharesMay 6, 2015P13,836$0.1169A3,987,630D
Common SharesMay 7, 2015P30,000$0.139A4,017,630D
Common SharesMay 7, 2015P20,000$0.134A4,037,630D
Common Sharesholding———4,318,958IPrivate Holding Company
Common Sharesholding———3,630,794D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options$0.11holding———Dec 23, 2014Dec 23, 2019Common Shares500,000500,000D
Stock Options$0.35holding———Jul 11, 2011Jul 11, 2016Common Shares200,000700,000D
Stock Options$0.10holding———Jun 18, 2013Jun 18, 2018Common Shares225,000925,000D
Warrants$0.25holding———Mar 21, 2014Sep 21, 2015Common Shares100,0671,025,067D